미국 프리마켓 특징주, 이슈 • $NVDA +0.30% : 중국, 빠르면 이번 분기 내 일부 H200 칩 구매 승인 예정 • $JEF -2.75% : 실적은 호조였으나, 투자자들은 First Brands 익스포저 관련 손실에 주목 • $STZ +2.0% : 시장 예상 상회 실적 발표 • $APLD +4.6% : 조정 EPS 및 매출 모두 예상치 상회 • $RTX +4.5% / $LMT +7.9% / $NOC +8.4% : 트럼프, 국방 예산을 기존 1.0조 달러 → 1.5조 달러로 증액해야 한다고 발언 • $ABBV -1.1% : 연간 조정 EPS 가이던스 하향 : $RVMD -7.3%, 인수설 부인 영향 • $GOOGL +1.1% : Cantor Fitzgerald, 투자의견 ‘중립’ → ‘비중확대’ 상향 • $MQ -9.5% : Mizuho, 투자의견 ‘시장수익률 상회’ → ‘중립’ 하향 • $AA -4.0% : JPMorgan, 투자의견 ‘중립’ → ‘비중축소’ 하향 • $NKE -1.1% : Needham, 투자의견 ‘매수’ → ‘보유’ 하향 MTS, @MSX_CN 로 국장, 미장 깔짝깔짝

🦍 ApeXOmni 再度拓宽资产边界，新增 6 大美股永续合约，RWA 交易体验全面升级 ApeXOmni 在 RWA 股票永续赛道上的推进再次迎来关键一步。依托 Chainlink 提供的高可靠数据网络，ApeXOmni 的 RWA 股票永续产品矩阵正式扩容，新上线的 6 个美股核心标的，现在已全部支持 最高 50 倍杠杆，让链上交易者能够在更丰富的资产池中灵活构建策略。 本次新增的标的覆盖从医药到科技的核心蓝筹资产，包括： $MRK （Merck）：全球医药巨头，稳健基本面驱动长期价值。 $ABBV （AbbVie）：生物制药龙头，高分红与稳定现金流为其提供强劲底盘。 $MSFT （Microsoft）：AI 与云计算时代的核心资产。 $GOOGL （Google）：搜索、广告与 AI 多赛道布局的科技巨头。 $AMZN （Amazon）：全球电商与云服务的重要基石。 $AAPL （Apple）：消费电子与生态护城河最深的全球品牌之一。 至此，ApeXOmni 从最初的 5 个股票永续扩展到如今 11 个高流动性标的，产品覆盖度与策略弹性大幅提升，使交易者能够在链上获得更接近传统市场的资产配置自由度。 ApeXOmni 的 RWA 股票永续以传统金融的稳健资产作为锚点，再结合链上的高效率机制与永续结构，使用户能够以更低成本、更快执行速度参与全球市场。无论是构建跨板块策略、做对冲配置，还是捕捉科技与医药板块的短期高波动行情，ApeXOmni 都提供了更专业、更实用的工具套件。 此次升级也标志着 ApeXOmni 在 RWA 方向的持续进化：在真实资产的基础上叠加衍生品扩展空间，让交易者在链上即可布局全球资产格局，不再受地域、时区与账户体系的限制。 📈 立即体验美股永续合约交易： https://t.co/x64UGsZVzg 🔥 加入 ApeX，见证下一次成长： https://t.co/W28FbpMGO4 💬 了解更多项目信息： Discord: https://t.co/5c9557cvhH Telegram: https://t.co/Av7oh1nFDF #ApeX #ApeXOmni #Buyback #DeFi #KaitoAI @ApeXProtocolCN @OfficialApeXdex

At close: $NVDA $AAPL $ABBV Generate heatmaps like this yourself at

#Downgrades - Dec 05, 2024 • $ABBV: Daiwa Securities Downgrades to Neutral from Buy - PT $180 • $AEO: JPMorgan Downgrades to Neutral from Overweight - PT $23 (from $27) • $ALLY: Wolfe Research Downgrades to Peerperform from Outperform • $AMAT: Morgan Stanley Downgrades to Underweight from Equalweight - PT $164 (from $179) • $CHWY: BNP Paribas Downgrades to Neutral from Outperform - PT $30 • $CNX: JPMorgan Downgrades to Underweight from Neutral - PT $37 (from $31) • $DVN: JPMorgan Downgrades to Neutral from Overweight - PT $191 • $F: Wolfe Research Downgrades to Underperform from Peerperform • $FOUR: Benchmark Downgrades to Hold from Buy • $FWONA: Seaport Global Securities Downgrades to Neutral from Buy • $GRAB: HSBC Downgrades to Hold from Buy - PT $5.50 (from $4.25) • $MRVI : Goldman Sachs Downgrades to Sell from Neutral - PT $4.25 (from $7) • $NAUT: Goldman Sachs Downgrades to Sell from Neutral - PT $1.75 (from $2.25) • $NCNO: Piper Sandler Downgrades to Neutral from Overweight - PT $38 • $OTIS: Barclays Downgrades to Underweight from Equalweight - PT $94 • $PB: Wolfe Research Downgrades to Peerperform from Outperform • $PFG: Morgan Stanley Downgrades to Underweight from Equalweight - PT $80 (from $86) • $RLMD: Mizuho Downgrades to Neutral from Outperform - PT $1 (from $23) • $ROP: Barclays Downgrades to Underweight from Overweight - PT $569 (from $625) • $SBRA: Mizuho Downgrades to Neutral from Outperform - PT $20 • $SM: JPMorgan Downgrades to Neutral from Overweight - PT $16 (from $15) • $VCYT: Goldman Sachs Downgrades to Neutral from Buy - PT $37 (from $38)